Company Financials

Intellia Therapeutics, Inc. Financials

United States dollar

business Intellia Therapeutics, Inc. Company Profile

Main Stock Listing

NASDAQ: NTLA

Market Capitalization $1.07 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE -1.75
Forward PE -2.57
Price to Sales TTM $18.54
Price to Book MRQ $1.42
Enterprise to Revenue 11.36
Enterprise to EBITDA -1.40

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin 0.00%
Operating Margin -808.86%
Return on Assets TTM -28.51%
Return on Equity TTM -52.11%

Income Statement

Revenue TTM $57,528,000
Revenue per Share TTM $0.55
Quarterly Revenue Growth 51.30%
Gross Profit TTM $-352,350,016
EBITDA $-468,774,016
Net Income to Common TTM $-445,806,016
Diluted EPS TTM $-4.25
Quarterly Earnings Growth YoY 51.27%

Balance Sheet

Total Cash MRQ $511,044,000
Total Cash per Share MRQ $4.41
Total Debt MRQ $
Total Debt to Equity MRQ 13.09
Current Ratio MRQ 6.21
Book Value per Share MRQ $6.46

Cash Flow

Operating Cash Flow TTM $-410,646,016
Levered Free Cash Flow TTM $-223,884,368

NTLA Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 115,787,285
Float Shares 110,195,958
Avg 10 Volume 3,065,040
Avg 30 Volume None
Shares Short 40,578,361
Short Ratio 9.39
Short % of Shares 39.30%
% Held by Insiders 4.50%
% Held by Institutions 86.94%

Stock Price Summary

Beta 2.14
Fifty Two Week Low $5.90
Fifty Two Week High $28.25
Fifty Two Week Change -38.98%
Day 50 MA $10.75
Day 200 MA $11.32

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date